1. Home
  2. ELTX vs OGI Comparison

ELTX vs OGI Comparison

Compare ELTX & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • OGI
  • Stock Information
  • Founded
  • ELTX 2011
  • OGI 2013
  • Country
  • ELTX United States
  • OGI Canada
  • Employees
  • ELTX N/A
  • OGI N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • OGI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELTX Health Care
  • OGI Health Care
  • Exchange
  • ELTX Nasdaq
  • OGI Nasdaq
  • Market Cap
  • ELTX 121.7M
  • OGI 135.1M
  • IPO Year
  • ELTX N/A
  • OGI N/A
  • Fundamental
  • Price
  • ELTX $4.95
  • OGI $1.04
  • Analyst Decision
  • ELTX Strong Buy
  • OGI
  • Analyst Count
  • ELTX 3
  • OGI 0
  • Target Price
  • ELTX $9.50
  • OGI N/A
  • AVG Volume (30 Days)
  • ELTX 39.4K
  • OGI 650.5K
  • Earning Date
  • ELTX 03-31-2025
  • OGI 05-13-2025
  • Dividend Yield
  • ELTX N/A
  • OGI N/A
  • EPS Growth
  • ELTX N/A
  • OGI N/A
  • EPS
  • ELTX N/A
  • OGI N/A
  • Revenue
  • ELTX N/A
  • OGI $115,451,336.00
  • Revenue This Year
  • ELTX N/A
  • OGI $50.11
  • Revenue Next Year
  • ELTX N/A
  • OGI $16.16
  • P/E Ratio
  • ELTX N/A
  • OGI N/A
  • Revenue Growth
  • ELTX N/A
  • OGI N/A
  • 52 Week Low
  • ELTX $3.34
  • OGI $0.96
  • 52 Week High
  • ELTX $11.45
  • OGI $2.37
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 23.49
  • OGI 40.39
  • Support Level
  • ELTX $7.54
  • OGI $0.96
  • Resistance Level
  • ELTX $8.13
  • OGI $1.16
  • Average True Range (ATR)
  • ELTX 0.55
  • OGI 0.06
  • MACD
  • ELTX -0.29
  • OGI 0.01
  • Stochastic Oscillator
  • ELTX 1.02
  • OGI 40.00

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Share on Social Networks: